Clinical trial Recruiting at 3 sites Phase 2 Interventional Ages 18 and up

Neutral fluid balance in adults with traumatic brain injury (LIMIT-TBI)

Official title: Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients: a Phase II Randomized Controlled Trial - LIMIT-TBI Trial

Run by Erasme University Hospital · NCT07625995 · Data updated 2026-11-12

This study tests whether keeping daily fluid balance around zero (within 500 mL) for the first 5 days in the ICU is feasible and safe for adults with traumatic brain injury.

More Traumatic Brain Injury trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment88 (estimated)
SponsorErasme University Hospital
Academic / other
Locations3 sites (Brussels and 2 other locations)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedDecember 31, 2028
Study endsFebruary 2029
Registry record updatedJune 4, 2026
Trial IDNCT07625995 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with traumatic brain injury admitted to the ICU, enrolled within 48 hours of ICU admission, and eligible per protocol.

Probably not a fit

Patients with hemorrhagic shock requiring immediate intervention or those with high-dose inotropic support at admission may not benefit or be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

LIMIT-TBI is a multicenter, international phase II trial that randomizes adults with traumatic brain injury within 48 hours of ICU admission to either a protocolized neutral fluid balance or standard care. The neutral strategy uses controlled fluid administration, vasopressors, and diuretics to reach a daily balance near 0 mL (±500 mL) for the first 5 days. The trial measures feasibility of achieving the target balance, organ complications, hemodynamics, ICU resource use, and 6-month mortality and neurological outcomes. It aims to clarify whether neutral fluid balance can improve outcomes without compromising safety in severe TBI. Enrollment is in ICU settings with ongoing monitoring of intracranial pressure when applicable.

Why it matters

Potential benefit: If successful, patients may experience improved brain perfusion and fewer fluid-related complications, potentially improving recovery after TBI.

How similar studies have gone: Previous observational data suggest fluid balance relates to outcomes, but randomized evidence in TBI is limited; this trial is among the first to test a neutral balance strategy in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients with traumatic brain injury (isolated or associated with extracranial injuries), with or without intracranial pressure monitoring
* Admission to the intensive care unit
* Age \>18 years
* Enrollment within 48 hours after ICU admission

Exclusion Criteria:

* Enrollment in another clinical trial not approved for co-enrollment
* Pregnancy or suspected pregnancy
* Concomitant hemorrhagic shock expected to require surgical treatment within 24 hours from inclusion or requiring massive transfusion protocol
* Hemodynamic instability at ICU admission, defined as heart rate \>120 beats/min and systolic arterial pressure \<100 mmHg despite at least 1 L of fluid resuscitation, or requirement for high-dose norepinephrine (\>0.5 mcg/kg/min) or any inotropic support
* Need for continuous venovenous hemodiafiltration (CVVHDF) at admission
* Expected survival \<48 hours

Where it's running

  • Erasme University Hospital
    Brussels, Belgium
    Recruiting
  • IRCCS Ospedale Policlinico San Martino
    Genova, Italy
    Recruiting
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.